ANI Pharmaceuticals, Inc. (BST:BSFA)

Market Cap	1.44B +32.5%
Revenue (ttm)	704.75M +48.9%
Net Income	29.10M
EPS	1.43
Shares Out	n/a
PE Ratio	49.65
Forward PE	10.23
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	40
Open	67.50
Previous Close	69.00
Day's Range	67.50 - 69.00
52-Week Range	49.60 - 84.00
Beta	n/a
RSI	49.21
Earnings Date	Mar 4, 2026

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 897
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: BSFA

Financial Performance

Financial numbers in USD